Hakim Singh Rajput "Design, Development and Evaluation of Natural Polymer-Based Matrix Systems for the Controlled Delivery of Repaglinide in Diabetes Management" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-9 | Issue-6 , December 2025, URL: Paper URL: To view or add a comment, sign in Boehringer Ingelheim Survodutide (BI 456906) Survodutide (also called BI 456906) is a dual glucagon receptor (GCGR) and GLP-1 receptor agonist designed to target both energy intake (via GLP-1 pathways) and energy expenditure (via glucagon pathways) , a mechanism derived from the natural hormone oxyntomodulin that may provide enhanced weight-loss effects
Szabo G, Mitchell M, McClain CJ, Dasarathy S, Barton B, McCullough AJ, et al
A glutathione S-aryltransferase of monkey liver
Multi-omic evaluation of metabolic alterations in multiple sclerosis identifies shifts in aromatic amino acid metabolism
Our experts will help you balance cost with results for a program that fits your lifestyle
It is FDA-approved and widely studied for both weight loss and diabetes management when prescribed under medical supervision